Document is current
Any future updates will be listed below
-
Authors
Tricard, Jérémy
Durand, Stéphanie
Rovini, Amandine
Gateau, Amy
Negroni, Luc
Chaunavel, Alain
Chermat, Anaelle
Jauberteau, Marie-Odile
Conti, Massimo
Akil, Hussein
Lalloué, Fabrice
-
Funding
Funding for this research was provided by:
Mark Laskar Award of the French Society of Thoracic and Cardiovascular Surgery
Ligue contre le Cancer, Comité de la Haute-Vienne
- License Information
-
More Information
Article History
Received: 5 September 2025
Accepted: 11 March 2026
First Online: 1 April 2026
Declarations
:
: The ExOnSite-Pro (Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer, Clinical Trial Register number: NCT04939324, ) [ ] is a prospective trial conducted from June 2021 to June 2024. Ethical approval was granted on May 21, 2021 by the independent protection committee SUD MEDITERRANEE III (approval number 2021.05.02 bis_21.03.15.45551, FRANCE). Written informed consent was obtained from all participants.
: The authors declare no competing interests.
